Dutch-American Research Team Aiming to Improve Colorectal Cancer Screening

SU2C-KWF_blog

Despite current screening efforts, colorectal cancer is the fourth most commonly diagnosed cancer worldwide and the fifth leading cause of cancer-related death. A newly formed trans-Atlantic team of researchers brought together by Stand Up To Cancer (SU2C) and the Dutch Cancer Society, KWF Kankerbestrijding (KWF), is hoping to change this by developing a new molecular test for stool-based colorectal cancer screening.

Read More

On the Road to Better Pancreatic Cancer Treatments

purpleSTRIDErun_300x300

Costas Lyssiotis, PhD, a 2013 Pancreatic Cancer Action Network-AACR Pathway to Leadership Grant recipient, is conducting research to understand the unique metabolism of pancreatic tumors and discover new therapeutic targets that can exploit the dependency of these tumors on the nutrients that fuel their growth.

Read More

Q&A With Lee Helman, MD, on New Cancer Targets and Therapeutics

Helman_Photo_external

The National Cancer Institute’s Lee Helman, MD, co-chair of the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, discusses what to expect this year, and peers into the future of targeted cancer therapies and immunotherapy.

Read More